Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours Β· Estimated delivery Sep 28 - Oct 3
Early human trials with single subcutaneous doses of SAR441255 in healthy subjects demonstrated improved glycemic control during a mixed-meal tolerance test, while also being well-tolerated
this is monitored at each clinical review and is dose-dependent Glucose: particularly relevant for patients with pre-diabetes, diabetes, or use of glucose-lowering medication
Taking matters into ones own hands by playing with dose sizes is a gamble: It might reduce side effects or costs in the short term, but it could also render the treatment ineffective or introduce new risks, all for unverified benefits
Were transparent about costs during consultations
US$ 21.58
US$ 27.05
US$ 27.01
US$ 26.69
US$ 27.74
